The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

USA: A recent study has highlighted the potential benefits of tirzepatide for overweight and obese adults with type 1 ...

US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...

Genetics or hormonal changes can pose challenges for losing weight, as you may know firsthand. Like many others struggling to ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

The two market leaders are targeting new obesity alternatives in their pipelines with an eye toward a triple threat.

As a federal crackdown on Ozempic-style copycats looms, Hims is trying a unique new strategy to lobby lawmakers.

In a nation where the battle against the stomach bulge is as intense as the love for butter parathas, a new player has ...

Chemically known as Tirzepatide ... Mounjaro, for instance, leads to an average 21.8 kg weight reduction at the highest dose (15 mg) and 15.4 kg weight loss at the lowest dose (5 mg) over a ...

Novo will license UTB251, a triple hormone receptor agonist that in mid-2023 achieved 24% weight reduction at 48 weeks in a ...